Astrana Health

Forecast & Rating11 analysts currently cover Astrana Health, with about 90.9% giving a positive rating — meaning they expect the stock to rise. The average price target is $49.33, about 22.4% upside from the current price of $40.31. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 74.3% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Astrana Health closely still see room for the stock to rise. Data as of Jul 14, 2026; for reference only and not investment advice.